http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16304bd435088ad2fb1a82fa8c25745b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Carlsson |
| name | Björn Carlsson |
| given-name | Björn |
| organization-name | Department of Immunology, Genetics, and Pathology, Science for Life Laboratory, Uppsala University, Uppsala SE-75185, Sweden ‡Division of Drug Research, Clinical Pharmacology, Department of Medical and Health Sciences, Linköping University, Linköping 58185, Sweden; and University of Gothenburg and AstraZeneca Gothenburg, Gothenburg, Sweden (B.C.) Institute of Medicine (P.J., B.C., L.S., L.M.S.C.), Sahlgrenska Academy, Gothenburg University, 413 45 Gothenburg, Sweden Research and Early Development, Cardiovascular, Renal, and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden Department of Clinical Neuroscience, Section of Ophthalmology, and International Pediatric Growth Research Center, Department of Pediatrics, The Queen Silvia Children's Hospital, 41685 Göteborg, Sweden; Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215; Department of Ophthalmology, Children's Hospital, Harvard Medical School, Boston, MA 02115; Endocrine Branch, National Institutes of Health, Bethesda, MD 20892; and Research Centre for Endocrinology and... Research Centre for Endocrinology and MetabolismDivision of Body Composition and Metabolism, Department of Internal MedicineSahlgrenska Academy at Göteborg University Göteborg Sweden Institute of Medicine, University of Gothenburg, Gothenburg, Sweden Department of Molecular and Clinical Medicine Institute of Medicine The Sahlgrenska Academy at Gothenburg University SE‐41345 Gothenburg Sweden Research and Early Development Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; Research and Early Clinical Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden Early Clinical Development AstraZeneca Mölndal Sweden From the Institutes of Medicine (L.M.S.C., K.S., P.J., J.C.A.-A., P.-A.S., M.T., B.C.) and Health and Care Sciences (P.-A.S.), Sahlgrenska Academy at the University of Gothenburg, and Early Cardiovascular, Renal, and Metabolism (CVRM), Biopharmaceuticals Research and Development, AstraZeneca (B.C.), Gothenburg, and the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna (M.P.) — both in Sweden; and the Public Health Promotion Unit, National Institute for Health and Welfare... Department of Metabolism and Cardiovascular Research, Institute of Medicine, The Sahlgrenska Academy at Göteborg University, 41345, Göteborg, Sweden Research and Early Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden Centre for Endocrinology and Metabolism, Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden. Department of Clinical Pharmacology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden Research and Early Development, Cardiovascular Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden Västrums läkarmottagning, Gusum. bjorna99@telia.com Department of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gröna Stråket 8, 413 45 Göteborg, Sweden Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA (C.B.).; Early Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (B.C.). |
Incoming Links
Total number of triples: 173.